QCM
UTMD icon

Quantinno Capital Management’s Utah Medical Products UTMD Stock Holding History

Quantinno Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
29,841
+6,146
+26% +$387K ﹤0.01% 1674
2025
Q4 		$1.33M Buy
23,695
+739
+3% +$42.8K ﹤0.01% 1577
2025
Q3 		$1.45M Buy
22,956
+12,266
+115% +$726K ﹤0.01% 1329
2025
Q2 		$608K Buy
+10,690
New +$581K ﹤0.01% 1537

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantinno Capital Management's UTMD Position: Q1 2026 in Review

Quantinno Capital Management increased its Utah Medical Products (UTMD) stake by 26% in Q1 2026, buying an estimated $387K and bringing the position to 29,841 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

Quantinno Capital Management first reported a position in UTMD in Q2 2025 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Quantinno Capital Management held 29,841 shares of Utah Medical Products worth $1.85M as of Q1 2026.
  • Quantinno Capital Management bought 6,146 Utah Medical Products shares in Q1 2026, an estimated $387K.
  • Utah Medical Products made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1674 holding.
  • Quantinno Capital Management first reported a position in Utah Medical Products in Q2 2025 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.